Seponeringsfrekvensen ved Lennox- Gastaut’ s syndrom på grund af bivirkninger var 8, 2% for patienter, der fik Inovelon og 0% for patienter, der fik placebo.
The discontinuation rate in Lennox-Gastaut syndrome due to adverse reactions was 8.2% for patients receiving Inovelon and 0% for patients receiving placebo.